Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VISION-1: Pilocarpine Ophthalmic Solution for Presbyopia
NCT04657172Phase 3Completed
- Sponsor
- Hyperion DeFi
- Start
- Dec 2020
- Primary completion
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of pilocarpine in presbyopia, sponsored by Hyperion DeFi. Started Dec 2020; status: completed.
02
Drugs
pilocarpine
03
Conditions
presbyopia
Beyond the preview
Go deeper on NCT04657172.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04657172.